These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32964759)

  • 21. Coronary in-stent restenosis: predisposing clinical and stent-related factors, diagnostic performance and analyses of inaccuracies in 320-row computed tomography angiography.
    Wan YL; Tsay PK; Chen CC; Juan YH; Huang YC; Chan WH; Wen MS; Hsieh IC
    Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():105-15. PubMed ID: 27106698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Coated Balloon Is Less Effective for Treatment of DES In-Stent Restenosis Both in Native Coronary Arteries and Saphenous Vein Grafts: Results From a Bicenter Registry.
    Resch M; Ostheim P; Endemann DH; Debl K; Buchner S; Birner C; Maier LS; Kerber S; Luchner A; Griese DP
    J Interv Cardiol; 2016 Oct; 29(5):461-468. PubMed ID: 27477024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.
    Feng C; Zhang P; Han B; Li X; Liu Y; Niu D; Shi Y
    Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thin-strut drug-eluting stents are more favorable for severe calcified lesions after rotational atherectomy than thick-strut drug-eluting stents.
    Lee Y; Tanaka A; Mori N; Yoshimura T; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    J Invasive Cardiol; 2014 Feb; 26(2):41-5. PubMed ID: 24486659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Clinical Outcomes after Treatment with Excimer Laser Coronary Atherectomy for In-Stent Restenosis of Drug-Eluting Stent.
    Ichimoto E; Kadohira T; Nakayama T; De Gregorio J
    Int Heart J; 2018 Jan; 59(1):14-20. PubMed ID: 29332914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Associated with Coronary In-Stent Restenosis after Drug-Eluting Stent Implantation in Patients on Chronic Hemodialysis.
    Sugita H; Motohiro M; Morishita S; Tanaka M; Tsujimoto S; Shiojima I
    Blood Purif; 2022; 51(4):383-389. PubMed ID: 34261068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
    Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
    Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry.
    Sugihara M; Miura S; Nishikawa H; Ike A; Mori K; Iwata A; Kawamura A; Saku K
    J Cardiol; 2013 Feb; 61(2):117-21. PubMed ID: 23159206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis.
    Üveges Á; Jenei C; Kiss T; Szegedi Z; Tar B; Szabó GT; Czuriga D; Kőszegi Z
    Int J Cardiovasc Imaging; 2019 Oct; 35(10):1755-1763. PubMed ID: 31127455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation.
    Redfors B; Maehara A; Witzenbichler B; Weisz G; Stuckey TD; Henry TD; McAndrew T; Mehran R; Kirtane AJ; Stone GW; Généreux P
    J Invasive Cardiol; 2017 Nov; 29(11):378-386. PubMed ID: 28623669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K; Li YJ; Gao S
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of excimer laser coronary atherectomy with contrast medium for underexpanded stent: The findings of optical frequency domain imaging.
    Ashikaga T; Yoshikawa S; Isobe M
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):946-9. PubMed ID: 25754354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for in-stent restenosis requiring rotational atherectomy.
    Hachinohe D; Kashima Y; Hirata K; Kanno D; Kobayashi K; Kaneko U; Sugie T; Tadano Y; Watanabe T; Shitan H; Haraguchi T; Enomoto M; Sato K; Fujita T
    J Interv Cardiol; 2018 Dec; 31(6):747-754. PubMed ID: 30175429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Wang Z; Yang J; Li C; Huang J; Fezzi S; Chen E; Cai W; Stankovic G; Wijns W; Chen L; Tu S
    Int J Cardiol; 2023 May; 378():11-19. PubMed ID: 36796487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry.
    Lee JM; Rhee TM; Hahn JY; Hwang D; Park J; Park KW; Kim HL; Kim SH; Chae IH; Doh JH; Jeon KH; Choi YJ; Park JS; Choi SH; Gwon HC; Koo BK; Alfonso F; Kim HS
    Int J Cardiol; 2017 Mar; 230():181-190. PubMed ID: 28043660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.